Patients presenting with a mild ischemic stroke or high-risk TIA believed to be related to atherosclerosis derive a benefit from dual antiplatelet therapy (DAPT) even when it’s started up to 72 hours ...

The following is a summary of “Delayed ischemic stroke after PED placement for aneurysms: optimal duration of dual ...

Patients and their family members should inquire about the use of DAPT after a stroke or TIA to consider if DAPT may be beneficial,” Solomonow said. The gender gap noted in the study could not ...

In acute coronary syndrome (ACS), a prasugrel (Effient)-based antiplatelet regimen passed muster for reducing bleeding ...

The optimal duration of dual antiplatelet therapy after PCI with stenting is one of the hottest topics in interventional cardiology in recent years. However, despite a high volume of new research ...

Presenting new 15-month data from the MASTER DAPT trial at the European ... defined as all-cause death, MI or stroke; and major or clinically relevant nonmajor bleeding. After 12 months ...

For the analyses, the researchers compared all DAPT regimens with all monotherapy regimens, showing a lower risk of recurrent ischemic stroke (primary outcome ... “So the whole field really—after many ...

Extending clot-preventing dual antiplatelet therapy (DAPT) beyond the recommended 12 months after coronary stenting ... myocardial infarction, stroke, and major bleeding (5.8% in the extended ...

The antiplatelet agent indobufen was noninferior to aspirin in combination with clopidogrel for dual antiplatelet therapy (DAPT) at 1 year after percutaneous coronary intervention (PCI), with ...

Removing aspirin from the DAPT regimen might reduce bleeding events early after PCI without compromising ... definite stent thrombosis, or stroke) at one month for non-inferiority.

Major exclusion criteria were a history of stroke or transient ischemic attack ... of dual antiplatelet therapy (DAPT), after which they were randomly assigned to one of three groups.

WASHINGTON -- Beyond bleeding alone, a regimen of dual antiplatelet therapy (DAPT) after transcatheter aortic valve replacement (TAVR) was associated with excess mortality, based on observational ...